2014 in review – new medicines listed on the PBS
Michael Wonder - January 2015
www.maestrodatabase.com
2014 saw the listing of 17 new medicines and 7 new combination products
on the Pharmaceutical Benefits Scheme. These new listings are summarised below. Seven of the 24 new listings are for use by patients
with a respiratory disease/condition.
New PBS listings for 2014
|
Month
|
Medicine
|
Disease/condition
|
Sponsor
|
|
January
|
Nil
|
|
|
|
February
|
Alogliptin benzoate with metformin
hydrochloride (NesinaMet)
|
Type 2 diabetes mellitus
|
Takeda
|
|
March
|
Linagliptin with metformin hydrochloride
(Trajentamet)
|
Type 2 diabetes mellitus
|
Boehringer Ingelheim
|
|
Saxagliptin hydrochloride with metformin
hydrochloride (Komboglyze XR)
|
Type 2 diabetes mellitus
|
AstraZeneca
|
|
|
April
|
Clobetasol propionate (Clobex)
|
Psoriasis
|
Galderma
|
|
Dolutegravir sodium (Tivicay)
|
HIV infection
|
ViiV
|
|
|
Glycopyrronium bromide (Seebri Breezhaler)
|
Chronic obstructive pulmonary disease
|
Novartis
|
|
|
Panitumumab (Vectibix)
|
Colorectal cancer
|
Amgen
|
|
|
May
|
Sapropterin dihydrochloride (Kuvan)
|
Hyperphenylalaninaemia
|
Merck Serono
|
|
Plerixafor (Mozobil)
|
Cancer
|
Genzyme
|
|
|
Tenofovir disoproxil fumarate with
emtricitabine and elvitegravir and cobicistat (Stribild)
|
HIV infection
|
Gilead
|
|
|
June
|
Tapentadol hydrochloride (Palexia SR)
|
Pain
|
CSL
|
|
July
|
Nil
|
|
|
|
August
|
Aclidinium bromide (Bretaris Genuair)
|
Chronic obstructive pulmonary disease
|
Menarini
|
|
Betaine (Cystadane)
|
Homocystinuria
|
Emerge Health
|
|
|
September
|
Macitentan (Opsumit)
|
Pulmonary arterial hypertension
|
Actelion
|
|
October
|
Eribulin mesylate (Halaven)
|
Breast cancer
|
Eisai
|
|
November
|
Indacaterol
maleate with glycopyrronium bromide (Ultibro Breezhaler)
|
Chronic obstructive pulmonary disease
|
Novartis
|
|
Perampanel
hemisesquihydrate (Fycompa)
|
Epilepsy
|
Eisai
|
|
|
December
|
Brentuximab
vedotin (Adcetris)
|
Non-Hodgkin’s lymphoma
|
Takeda
|
|
Enzalutamide
(Xtandi)
|
Prostate cancer
|
Astellas
|
|
|
Fluticasone furoate with vilanterol trifenatate
(Breo Ellipta)
|
Asthma, chronic obstructive pulmonary disease
|
GSK
|
|
|
Ivacaftor
(Kalydeco)
|
Cystic fibrosis
|
Vertex
|
|
|
Simeprevir
sodium (Olysio)
|
Hepatitis C
|
Janssen-Cilag
|
|
|
Umeclidinium
bromide (Incruse Ellipta)
|
Chronic obstructive pulmonary disease
|
GSK
|
|
|
Vilanterol
trifenatate with umeclidinium bromide (Anoro Ellipta)
|
Chronic obstructive pulmonary disease
|
GSK
|
©
Wonder Drug Consulting Pty Ltd, 2015.
No comments:
Post a Comment